Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LovaMiX: Minocycline and Lovastatin in Fragile X Syndrome
NCT02680379Phase 2Completed
- Sponsor
- Université de Sherbrooke
- Start
- Mar 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline, lovastatin in Fragile X syndrome (FXS), sponsored by Université de Sherbrooke. Started Mar 2016; status: completed.
02
Drugs
minocyclinelovastatin
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT02680379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680379.